Mark Enstrom
Impact in
- Oncology top 10%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
- Hematology top 10%
- Hematopoietic Stem Cell Transplantation
Papers in
- Genetics 8
- Virus-based gene therapy research 7
- Bacterial Genetics and Biotechnology 1
-
- Hematopoietic Stem Cell Transplantation 4
- Co-authors
- Hans‐Peter Kiem (11 shared papers)Jennifer E. Adair (8 shared papers)Dnyanada Pande (9 shared papers)Stefan Radtke (9 shared papers)Martin E. Wohlfahrt (2 shared papers)David G. Maloney (1 shared paper)Alyssa Sheih (1 shared paper)Hannah A. DeBerg (1 shared paper)
- Journals
- Molecular Therapy — Methods & Clinical Development (4 papers)Blood (2 papers)Science Translational Medicine (2 papers)Nature Communications (2 papers)Human Gene Therapy (1 paper)
- Partner nations
- United StatesGermanyIndia
In The Last Decade
Mark Enstrom
14 papers receiving 416 citations
Peers
Comparison fields: 5 of 32
- Oncology 191
- Hematology 84
- Genetics 92
- Virology 7
- Molecular Biology 100
Countries citing papers authored by Mark Enstrom
This map shows the geographic impact of Mark Enstrom's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Enstrom with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Enstrom more than expected).
Fields of papers citing papers by Mark Enstrom
This network shows the impact of papers produced by Mark Enstrom. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Enstrom. The network helps show where Mark Enstrom may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Enstrom, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 225 | |
| 2 | 2017 | 87 | |
| 3 | 2020 | 38 | |
| 4 | 2020 | 17 | |
| 5 | 2023 | 13 | |
| 6 | 2012 | 12 | |
| 7 | 2025 | 11 | |
| 8 | 2020 | 9 | |
| 9 | 2021 | 5 | |
| 10 | 2022 | 2 | |
| 11 | 2025 | 2 | |
| 12 | 2021 | 1 | |
| 13 | 2025 | 1 | |
| 14 | 2026 | 1 | |
| 15 | 2026 | 0 | |
| 16 | 2026 | 0 | |
| 17 | 2026 | 0 |
About Mark Enstrom
Mark Enstrom is a scholar working on Genetics, Hematology, Molecular Biology, Genetics and Radiology, Nuclear Medicine and Imaging, having authored 17 papers that have together received 424 indexed citations. Recurring topics across this work include Virus-based gene therapy research (7 papers), CRISPR and Genetic Engineering (6 papers), Hematopoietic Stem Cell Transplantation (4 papers), RNA Interference and Gene Delivery (2 papers), Radiopharmaceutical Chemistry and Applications (1 paper), CAR-T cell therapy research (1 paper), Bacterial Genetics and Biotechnology (1 paper) and Single-cell and spatial transcriptomics (1 paper). The work is most often cited by research in Oncology (191 citations), Hematology (84 citations), Genetics (92 citations), Virology (7 citations) and Molecular Biology (100 citations). Mark Enstrom has collaborated with scholars based in United States, Germany and India. Frequent co-authors include Hans‐Peter Kiem, Jennifer E. Adair, Dnyanada Pande, Stefan Radtke, Martin E. Wohlfahrt, David G. Maloney, Alyssa Sheih, Hannah A. DeBerg, Stanley R. Riddell and Vivian H. Gersuk. Their work appears in journals such as Molecular Therapy — Methods & Clinical Development, Blood, Science Translational Medicine, Nature Communications and Human Gene Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.